12:37 EDT AstraZeneca (AZN) up 1% to $85.55 after MSNBC report on Trump pact
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca’s New Trial Targets Sepsis-Related Kidney Injury
- AstraZeneca Launches New Study on NSCLC Treatment Patterns
- AstraZeneca’s New Study Targets Improved Treatment for Elderly LBCL Patients
- AstraZeneca’s OPTIMISE-CKD Study: Insights into Chronic Kidney Disease Management
- AstraZeneca’s Latest Study on AZD5004: Key Insights for Investors